Paliperidone 6-Month IM Injection bulk supplier for pharma manufacturers

Paliperidone 6-Month Im Injection 1,092 mg, 1,560 mg Suppliers & Bulk Manufacturers

Available Forms: Once-6-Month IM Injection

Available Strengths: 1,092 mg, 1,560 mg

Reference Brands: Invega Hafyera®(US)

Paliperidone is an atypical antipsychotic that antagonizes dopamine D2 and serotonin 5-HT2A receptors, helping to reduce psychotic symptoms and stabilize mood. The 6-month intramuscular injection offers long-term treatment for schizophrenia in adults, improving adherence by reducing dosing frequency. It maintains steady plasma levels, minimizing relapse risk in stabilized patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Paliperidone 6-month intramuscular injection (brand name: Invega Hafyera) is FDA-approved in the United States for the maintenance treatment of schizophrenia in adults stabilized on 1-month or 3-month paliperidone formulations. It is designed to improve adherence and reduce relapse by offering long-term dosing. In the European Union, this 6-month version is not yet widely approved, requiring a new EMA submission via the centralized procedure. Regulatory requirements include GMP-compliant long-acting injectable technology, bridging pharmacokinetic studies, and thorough safety evaluations. U.S. labelling carries boxed warnings for elderly dementia-related psychosis. Explore sourcing options at Pharmatradz.com — your B2B pharma partner.

Paliperidone 6-Month Im Injection — third party manufacturing & bulk supply

Paliperidone 6-Month Im Injection 1,092 mg, 1,560 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Paliperidone 6-Month Im Injection is supplied as Once-6-Month IM Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Paliperidone 6-Month Im Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Paliperidone 6-Month Im Injection →

Back to Listing

Frequently Asked Questions

Paliperidone 6-Month IM Injection is listed as Once-6-Month IM Injection in 1,092 mg, 1,560 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Paliperidone 6-Month IM Injection is referenced against Invega Hafyera®(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.